The content in the following module was written or revised by the following.

Paul Boesch, DO

Christopher Carroll, MD, MS, FCCP

Mary E. Cataletto, MD, FCCP (Editor in Chief, 2014)

Megan K. Dishop, MD

Holger Link, MD

Julie P. Katkin, MD, FAAP, FCCP

Anastassios C. Koumbourlis, MD, MPH, FCCP

Nadia Krupp, MD

Edward Y. Lee, MD, MPH

Susan Millard, MD, FAAP, FCCP

Mary Nevin, MD, FCCP

Clement L. Ren, MD, FCCP (Deputy Editor, 2014)

Carol L. Rosen, MD, FCCP

Elizabeth Scarlett, MD

Marianna Sockrider, MD, DrPH

Paul C. Stillwell, MD, FCCP

Daniel Weiner, MD, FCCP

The pediatric pulmonary medicine content was validated on March 29, 2022, and is accredited until March 28, 2025. In accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the content in this library is subject to regular validation review for relevancy and accuracy. As a result, library content can be modified, deleted, or retired by CHEST at any time to reflect new developments in medical science. The accreditation duration of content is established by the American College of Chest Physicians (CHEST) in accordance with the ACCME’s policies.

CHEST is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CHEST designates the enduring material found in the Pediatric Pulmonary Medicine Module for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

-11.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and

-11.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit.

The disclosures from content found in this module include the following:

The following had disclosed to CHEST relevant financial relationship(s) with commercial interest(s):

Clement Ren, MD, FCCP

Grant monies (from industry related sources): Medimmune

Consultant fee, speaker bureau, advisory committee, etc: Consultant; Genentech, Speaker; Novartis, Gilead, Merck

Daniel Weiner, MD, FCCP

Grant monies (from industry related sources): Principal Investigator Respirtech, Inc.

Consultant fee, speaker bureau, advisory committee, etc.: Caremark CVS

Marianna Sockrider, MD, DrPH

Grant monies (from industry related sources): GlaxoSmithKline

The following have indicated to CHEST that they have no relevant financial relationships with commercial interests to disclose:

Mary Cataletto, MD, FCCP

Christopher Carroll, MD, MS, FCCP

Paul Boesch, DO

Nadia Krupp, MD

Julie Katkin, MD, FCCP

Holger Link, MD

Susan Millard, MD, FCCP, FAAP

Anastassios Koumbourlis, MD, MPH, FCCP

Megan Dishop, MD

Edward Y. Lee, MD, MPH

Carol Rosen, MD, FCCP

Elizabeth Scarlett, MD

Mary Nevin, MD, FCCP

Paul Stillwell, MD, FCCP

CHEST Staff

The following staff members had indicated no relevant financial relationships with commercial interests to disclose.

Conrad Allen

Morgan Bashford

Kaitlyn Chisholm Dada, MA, MFA

Claudia Egresits

Carolyn Jones

Martha Zaborowski Pascale, CPM

Richard Schuch, EdD